← Back to Search

Behavioural Intervention

Treadmill Training for Mild Cognitive Impairment and Alzheimer's Disease

N/A
Waitlist Available
Led By Trisha Kesar, PT, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy Older Adults: No history of neurologic, musculoskeletal, or medical conditions affecting walking
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-training), week 2 (post-training)
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to study how Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) affect the ability to adapt while walking. Understanding this could help improve walking function in individuals with

Who is the study for?
This trial is for older adults who can walk without help and have been formally diagnosed with Mild Cognitive Impairment or Alzheimer's Disease by a neurologist. They should not have any medical conditions that affect walking, no recent hospitalizations, and must be able to perform study tasks.
What is being tested?
The study tests how well people with MCI or AD adapt their walking on a split-belt treadmill over five sessions. The goal is to understand the impact of these cognitive conditions on the ability to adjust walking patterns, which could lead to better exercise-based treatments.
What are the potential side effects?
While specific side effects are not detailed for this type of physical intervention, participants may experience fatigue or discomfort from the treadmill exercises. There might also be an increased risk of falls due to balance challenges during adaptation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have no health conditions that affect my ability to walk.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-training), week 2 (post-training)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-training), week 2 (post-training) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in 10-Meter Overground Walk Test
Change in 6-Minute Walk Test
Change in Adaptation Magnitude Assessed as Peak Step Length Symmetry
+3 more
Secondary study objectives
Change in De-adaptation Magnitude Assessed as Peak Step Length Symmetry
Change in De-adaptation Rate Assessed as the Number of Steps to Reach Step Symmetry
Change in Double-support Duration
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Split-beltTreadmill-based Locomotor Adaptation in Older Adults with MCIExperimental Treatment1 Intervention
Older adults with mild cognitive impairment (MCI) complete 5 split-belt treadmill walking exercise sessions over a 2-week period.
Group II: Split-beltTreadmill-based Locomotor Adaptation in Older Adults with ADExperimental Treatment1 Intervention
Older adults with Alzheimer's Disease (AD) complete 5 split-belt treadmill walking exercise sessions over a 2-week period.

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,697 Previous Clinical Trials
2,603,908 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,788 Previous Clinical Trials
28,184,762 Total Patients Enrolled
Trisha Kesar, PT, PhDPrincipal InvestigatorEmory University
5 Previous Clinical Trials
188 Total Patients Enrolled
~7 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top